PUMA BIOTECHNOLOGY, INC. Amortization of Lease Incentives
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Amortization of Lease Incentives of $3.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfLeaseIncentives · last filed 2019-03-01
- PUMA BIOTECHNOLOGY, INC. amortization of lease incentives for the quarter ending 2016-12-31 was $0.00.
- PUMA BIOTECHNOLOGY, INC. amortization of lease incentives for the quarter ending 2016-09-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. amortization of lease incentives for the quarter ending 2015-12-31 was $0.00.
- PUMA BIOTECHNOLOGY, INC. amortization of lease incentives for the quarter ending 2015-09-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. amortization of lease incentives for fiscal 2016 was $3.00M, a 1574.30% increase from fiscal 2015.
- PUMA BIOTECHNOLOGY, INC. amortization of lease incentives for fiscal 2015 was $179.00K, a 6.77% decline from fiscal 2014.
- PUMA BIOTECHNOLOGY, INC. amortization of lease incentives for fiscal 2014 was $192.00K.
| Period end | Amortization of Lease Incentives 3 month | Amortization of Lease Incentives 6 month | Amortization of Lease Incentives 9 month | Amortization of Lease Incentives 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $3.00M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $3.00M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $3.00M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $0.00 derived: sum of 3 quarters · filed 2018-03-09 | $179.00K 10-K · filed 2018-03-09 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $179.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $179.00K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $179.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $192.00K 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |